- Home
- BSBK vs NSPR Comparison
BSBK vs NSPR Comparison
Compare BSBK & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BSBK
- NSPR
- Stock Information
- Founded
- BSBK 1893
- NSPR 2005
- Country
- BSBK United States
- NSPR United States
- Employees
- BSBK N/A
- NSPR N/A
- Industry
- BSBK Banks
- NSPR Medical/Dental Instruments
- Sector
- BSBK Finance
- NSPR Health Care
- Exchange
- BSBK Nasdaq
- NSPR Nasdaq
- Market Cap
- BSBK 89.2M
- NSPR 79.7M
- IPO Year
- BSBK N/A
- NSPR N/A
- Fundamental
- Price
- BSBK $7.03
- NSPR $2.55
- Analyst Decision
- BSBK
- NSPR Strong Buy
- Analyst Count
- BSBK 0
- NSPR 2
- Target Price
- BSBK N/A
- NSPR $4.75
- AVG Volume (30 Days)
- BSBK 3.1K
- NSPR 49.0K
- Earning Date
- BSBK 05-02-2025
- NSPR 05-13-2025
- Dividend Yield
- BSBK N/A
- NSPR N/A
- EPS Growth
- BSBK N/A
- NSPR N/A
- EPS
- BSBK N/A
- NSPR N/A
- Revenue
- BSBK $12,047,614.00
- NSPR $7,009,000.00
- Revenue This Year
- BSBK N/A
- NSPR $28.93
- Revenue Next Year
- BSBK N/A
- NSPR $172.18
- P/E Ratio
- BSBK N/A
- NSPR N/A
- Revenue Growth
- BSBK N/A
- NSPR 12.96
- 52 Week Low
- BSBK $6.40
- NSPR $1.81
- 52 Week High
- BSBK $8.66
- NSPR $3.80
- Technical
- Relative Strength Index (RSI)
- BSBK 42.49
- NSPR 42.86
- Support Level
- BSBK $6.72
- NSPR $2.37
- Resistance Level
- BSBK $7.40
- NSPR $2.68
- Average True Range (ATR)
- BSBK 0.36
- NSPR 0.16
- MACD
- BSBK -0.01
- NSPR 0.00
- Stochastic Oscillator
- BSBK 38.94
- NSPR 71.15
About BSBK Bogota Financial Corp.
Bogota Financial Corp is a New Jersey-based bank. It offers personal and business banking services such as savings, certificates of deposits, online banking, loans, and many more. The Bank generally grants residential, commercial, and consumer loans to, and accepts deposits from customers in New Jersey.
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.